HOUSTON: The study found that 570 clinics in almost every state in the U.S. are marketing unproven stem cell interventions for a range of ailments, including orthopaedic injuries and neurological disorders. The two authors of the study, Paul Knoepfler and Leigh Turner, said this is Read More »

DALLAS: A recent study by researchers from the Mayo Clinic found that sending text messages on a smartphone creates a brand-new brain rhythm, different from any that have been previously described. This brainwave was found only in subjects who were text messaging, not in those Read More »

BOSTON: Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD), announced today an agreement with the Dutch biotech company Crossbeta Biosciences B.V. in order to utilize Crossbeta’s proprietary technology in support of Probiodrug’s biomarker development activities.

AD, Read More »

SAN DIEGO: Salk Institute scientists have found preliminary evidence that tetrahydrocannabinol (THC) and other compounds found in marijuana can promote the cellular removal of amyloid beta, a toxic protein associated with Alzheimer’s disease.

While these exploratory studies were conducted in neurons grown in the laboratory, Read More »